Login
← Go Back
Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com
Stock Price vs Company Growth
1d
0.4%
1w
0.9%
1m
31.1%
3m
70.2%
6m
143.9%
1y
84.7%
5y
24.4%
10y
10.9%
all
21.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 812 0.4%
468
826
Company Overview
Sales
1,682 Cr
Growth: 20.0%
Profit after Tax
272 Cr
Growth: 24.7%
Mid Cap
15,881 Cr
P/E: 57.2x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 1,682
Growth 20.0%
EBITDA 28.4%
P/S 9.4x
Dividend 0.1%
P/E 57.2x
Book Value ₹ 138
PEG Ratio 2.9x
ROE 10.6%
P/B 5.9x
Shareholding Pattern
Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Belongs to (13 Indices) view more
Investors (148)
cohesion...
vishnuka...
ubs.ag
Followers (8)
nitin2
keerthi
deepak